WASHINGTON (AP) — U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called ...

Fecal microbiota transplantation (FMT) delivered via oral capsule or colonic delivery demonstrated similar safety and effectiveness for recurrent Clostridioides difficile infection (CDI) in a ...

U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants.

WASHINGTON — U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal ...

U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants.

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. On April 26, the Food and Drug Administration approved the first ...

C. diff infection can cause diarrhea. While it may lead your poop to change color, there are no specific colors that are definitive evidence of having C. diff. According to the Centers for Disease ...

Hold your nose and don't spit out your coffee: Doctors have found a way to put healthy people's poop into pills that can cure serious gut infections -- a less yucky way to do "fecal transplants." ...

C. diff colitis is inflammation of a person’s colon due to contagious bacteria. Most people with C. diff colitis fully recover, but in rare cases the condition can be life threatening. It is possible ...

Harvard researchers make the case for people storing their poop when young, in order to restore their gut microbiomes later in life. Reading time 3 minutes Experts at Harvard and elsewhere are ...

This photo provided by Seres Therapeutics shows manufacturing equipment for oral microbiome therapeutic capsules in the company's Cambridge, Mass., facility in May 2022. (Genevieve de Manio/Seres ...